Navigation Links
NFL Docs Urge More Caution With Key Pain Med
Date:9/11/2012

TUESDAY, Sept. 11 (HealthDay News) -- New recommendations by NFL team doctors suggest increased caution in the use of the pain reliever ketorolac tromethamine (Toradol) by professional football players.

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID). Athletes have long taken NSAIDs for pain prevention and relief before, during and after competition. But the recommendations by a task force developed through the NFL Team Physicians Society suggests more careful use of ketorolac.

The recommendations are published in the September/October issue of the journal Sports Health: A Multidisciplinary Approach.

"Ketorolac has been used most frequently as an analgesic pain reliever following strains, sprains and overuse injuries. Our recommendations on its use in NFL players hopefully will help minimize the risk of complications and allow for all parties involved in the health of athletes to better understand, how, when and why to use ketorolac more effectively and safely," lead author Dr. Matthew Matava, president-elect of the NFL Team Physicians Society, said in a journal news release.

The recommendations on ketorolac indicate:

  • It should be given only under the direct supervision and order of a team physician.
  • It should not be used before competition as a means of reducing anticipated pain.
  • It should only be used in players diagnosed with an injury or condition who are listed on the teams' latest injury report.
  • It should be given in the lowest effective therapeutic dose and for no more than five days.
  • It should be given by mouth under typical circumstances.
  • It should not be given by intramuscular and intravenous injection except following an acute, game-related injury where significant bleeding is not expected.
  • It should not be taken concurrently with other NSAIDs.

More information

The U.S. Food and Drug Administration offers a guide to the safe use of pain medicine.

-- Robert Preidt

SOURCE: Sports Health: A Multidisciplinary Approach, news release, Aug. 28, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Precautions for tick-borne disease extend beyond Lyme
2. Use Caution When Exercising in Hot Weather
3. Supplements and cancer prevention: A cautionary tale
4. Penn study cautions use of drugs to block niacin flush
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NFL Docs Urge More Caution With Key Pain Med
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University ... specialty academic programs. , Answering to the increasing demand for curricular specializations, the ... law, and environmental and land use law. ,  , “The demand for lawyers ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Woodlands at John Knox ... new model of care for living and healing, celebrated its grand opening, today. The ... a Real Home provided by Empowered Staff. , “This is an incredibly fulfilling time ...
(Date:5/26/2016)... ... May 26, 2016 , ... MadgeTech will be showcasing its line of ... Warner, New Hampshire at the MadgeTech headquarters. With products sold in more than 100 ... government agencies, including NASA. , In 2012, NASA strategically set up 17 RHTemp101A ...
(Date:5/26/2016)... ... ... An April Gallup survey found rising health care costs to be the top ... Living (SHSL) may not share those same worries thanks to a new bundled ... while holding the line on increasing their contributions, including premiums, deductibles and the portions ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership ... solutions, today announced the organization has earned its ISO 13485 certification, indicating the ... compliant with all rules and policies associated with ISO quality standard 13485. ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... the Dario™ Diabetes Management Tool, today announced that the Company,s ... the Marcum MicroCap Conference being held June 1-2 in ... Invitational, being held June 7-9 in Los Angeles, ... will discuss recent corporate and operational milestones, including the U.S. ...
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
Breaking Medicine Technology: